Premium
This is an archive article published on November 24, 2020

1 crore health workers to get first dose; PM Modi to hold meeting with CMs today

The creation of a database on healthcare and frontline workers -- a process that is now in the final stages -- comes ahead of PM Modi's detailed engagement with Chief Ministers on vaccine administration on Tuesday morning.

PM Modi, prime minister narendra modi, education news,Prime Minister Narendra Modi (Image Source: PIB)

Ahead of a crucial meeting on vaccine administration that Prime Minister Narendra Modi will hold Tuesday morning with Chief Ministers, top government sources told The Indian Express that one crore frontline healthcare workers have been identified to receive the first dose of whichever vaccine is available against the novel coronavirus infection early next year.

The sources, who are part of the expert group on vaccine administration, said they have “moved into an advance stage” of building a database for the first priority group — “frontline healthcare workers” — who will receive the first dose during the immunisation drive, if and when a particular vaccine is cleared by the Indian regulator for commercial use.

“We have received a substantial response from the states. Ninety two per cent of all government hospitals across all states have provided data. Around 56 per cent of private-sector hospitals have provided data. We are at an advanced stage,” a top government source said.

Story continues below this ad

“What has emerged is that the entire group (of frontline health care workers) is approximate around 1 crore,” the source said.

Read | Oxford vaccine ‘highly effective’; Pune lab says in India very soon

The creation of a database on healthcare and frontline workers — a process that is now in the final stages — comes ahead of PM Modi’s detailed engagement with Chief Ministers on vaccine administration on Tuesday morning. Dr V K Paul, member, NITI Aayog, and Rajesh Bhushan, Union Health Secretary, both of whom co-chair the expert group, are expected to make a detailed presentation in the meeting, senior officials confirmed.

The backend preparation for the largest immunisation drive also comes at a time when the Centre expects to receive and utilise 400-500 million doses and cover approximately 20-25 crore people by July 2021.

Laying out the distribution sequence for Covid vaccines that are expected to be available in India, Union Health Minister Dr Harsh Vardhan had in October said the first priority would be for those facing occupational hazards from the virus and exposure risk, indicating that healthcare professionals at the frontline would be among the early recipients.

Story continues below this ad

Sources said state governments have also provided “granular” details on frontline healthcare workers under different categories, including “allopathic doctors, AYUSH doctors; nurses deployed in hospitals, ASHA (Accredited Social Health Activists) workers and ANMs (Auxiliary Nurse Midwifery)”.

“However, within the main group, there is no further priority. Once we start immunising frontline healthcare workers, will do it for the entire 1 crore people, from start to finish,” a source said.

Students of medicine and nursing students and faculty members will also be involved in the training and implementation of the immunisation programme.

Over the last one week, the Prime Minister has been briefed on the preparations, including that the digital platform for vaccine administration and distribution has been prepared and test runs are underway in partnership with state- and district-level stakeholders.

Story continues below this ad

Currently, five vaccine candidates are in advanced stages of development in India and one is in the early stages. While enrollment for Phase 3 of the Oxford vaccine candidate tested by Serum Institute is complete, Bharat Biotech has just begun Phase 3 trials, and Zydus Cadila has completed Phase 2 trials. Russia’s Sputnik-V, being tested in collaboration with Dr Reddy’s, has begun Phase 2-3 trials. Biological E is conducting an early Phase 1-2 trial.

Sources said details on augmentation of cold chains and procurement of syringes and needles were also discussed during the meeting. “From the existing 28,000 cold storage points, we have added 1,000 more points within the government facility itself. We are also procuring additional walk-in coolers, walk-in fridges and deep freezers,” sources said.

x

Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies. With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health. His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award. Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time. Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Loading Taboola...
Advertisement
Advertisement